Related Experiment Videos
[Pemphigoid and acquired hemophilia]
E Lightburn1, J J Morand, B Graffin
1Service de Dermatologie, HIA Laveran, 13998 Marseille Armées.
Annales De Dermatologie Et De Venereologie
|March 23, 2002
Summary
Bullous pemphigoid can be associated with acquired haemophilia, a rare bleeding disorder. This case report highlights a successful treatment approach combining immunosuppressants with factor replacement therapy for remission.
Area of Science:
- Hematology
- Dermatology
- Immunology
Background:
- The rare association between bullous pemphigoid (BP) and acquired haemophilia (AH) presents unique clinical challenges.
- Acquired haemophilia, often idiopathic or linked to autoimmune conditions, carries a high mortality rate.
Observation:
- A 74-year-old male developed acquired haemophilia with high titers of anti-factor VIII antibodies following bullous pemphigoid onset and reduced corticosteroid therapy.
- Initial immunosuppressive treatments (cyclosporine, prednisone, azathioprine, cyclophosphamide) were ineffective in controlling the bleeding disorder.
Findings:
- Combination therapy involving recombinant activated factor VII, human immunoglobulins, and prednisone-azathioprine achieved clinical and biological remission.
- This treatment strategy effectively managed the hemorrhagic complications and reduced anti-factor VIII antibody levels.
Implications:
- This case underscores the importance of considering acquired haemophilia in patients with bullous pemphigoid presenting with unexplained bleeding.
- Aggressive management combining hemostatic support and immunosuppression is crucial for improving outcomes in this rare co-occurrence.
- Further research into the pathomechanisms linking these autoimmune conditions may reveal novel therapeutic targets.